JPS6231919B2 - - Google Patents
Info
- Publication number
- JPS6231919B2 JPS6231919B2 JP4257279A JP4257279A JPS6231919B2 JP S6231919 B2 JPS6231919 B2 JP S6231919B2 JP 4257279 A JP4257279 A JP 4257279A JP 4257279 A JP4257279 A JP 4257279A JP S6231919 B2 JPS6231919 B2 JP S6231919B2
- Authority
- JP
- Japan
- Prior art keywords
- amoxicillin
- reaction
- culture
- hydantoin
- hydroxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims description 40
- 229960003022 amoxicillin Drugs 0.000 claims description 40
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims description 40
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims description 19
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 244000005700 microbiome Species 0.000 claims description 14
- 241000589565 Flavobacterium Species 0.000 claims description 12
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims description 5
- 229940091173 hydantoin Drugs 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000000243 solution Substances 0.000 description 21
- UMTNMIARZPDSDI-UHFFFAOYSA-N 5-(4-hydroxyphenyl)imidazolidine-2,4-dione Chemical compound C1=CC(O)=CC=C1C1C(=O)NC(=O)N1 UMTNMIARZPDSDI-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 238000006911 enzymatic reaction Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000010902 straw Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AJSRHILLPJYTMO-UHFFFAOYSA-N 1-(4-hydroxyphenyl)imidazolidine-2,4-dione Chemical compound C1=CC(O)=CC=C1N1C(=O)NC(=O)C1 AJSRHILLPJYTMO-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- QYASYXWODYQOFU-UHFFFAOYSA-N 5-(1h-indol-2-ylmethyl)imidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1CC1=CC2=CC=CC=C2N1 QYASYXWODYQOFU-UHFFFAOYSA-N 0.000 description 1
- SBKRXUMXMKBCLD-UHFFFAOYSA-N 5-(2-methylsulfanylethyl)imidazolidine-2,4-dione Chemical compound CSCCC1NC(=O)NC1=O SBKRXUMXMKBCLD-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- -1 iron ions Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
æ¬çºæã¯ã¢ã¢ãã·ã·ãªã³ã®é
µçŽ çè£œé æ³ã«é¢
ããæŽã«è©³çްã«ã¯ïŒâã¢ããããã·ã©ã³é
žãšïŒâ
ïŒïœâãã€ãããã·ããšãã«ïŒããã³ãã€ã³ãã
çŽæ¥ã¢ã¢ãã·ã·ãªã³ã補é ããã¢ã¢ãã·ã·ãªã³ã®
é
µçŽ çè£œé æ³ã«é¢ããã
ã¢ã¢ãã·ã·ãªã³ïŒïŒâãâïŒâïŒâαâã¢ãã
ââããããã·ããšãã«ã¢ã»ãã¢ãããããã·
ã©ã³é
žïŒã¯ãã°ã©ã éœæ§èåã³ã°ã©ã é°æ§èã«å¯Ÿ
ãåºç¯å²ã«åŒ·ãæèåãæããåªããææ§ç©è³ªã§
ãããããã现èã®æ±æã«èµ·å ãã人éãåç©ã®
諞ææçã®ååŠæ²»çå€ãšããŠè¿å¹Žç¹ã«éèŠãªäœçœ®
ãå ããããã«ãªã€ãŠããŠããã
ã¢ã¢ãã·ã·ãªã³ã®è£œé æ³ã¯ååŠåææ³åã³é
µçŽ
çè£œé æ³ãç¥ãããŠããããååŠçåææ³ã¯ä¿è·
åºã®å°å
¥åã³ãã®è±é¢ãã¢ã·ã«äŸäžäœã®æŽ»æ§èªå°
äœãžã®å€æçã®å·¥çšãå¿
èŠãšããå
šåå¿å·¥çšãè€
éå€å²ã«äºããããããã«ä»£ããã®ãšããŠé
µçŽ ç
è£œé æ³ãéçºãããŠãããããããªããåŸæ¥ç¥ã
ããŠããé
µçŽ çè£œé æ³ã¯åºè³ªã®ïŒâã¢ããããã·
ã©ã³é
žãšïŒ€âïœâããããã·ããšãã«ã°ãªã·ãªã³
掻æ§èªå°äœãã·ãŠãŒãã¢ãã¹å±ãã¢ã¯ãã¢ãã¯ã¿
ãŒå±ãããã«ã¹å±çã«å±ãã埮çç©ã®èäœåã¯ã
ã®åŠçç©ã®ååšäžã§é
µçŽ åå¿ãããã¢ã¢ãã·ã·ãª
ã³ã補é ããæ¹æ³ã§ãäžå·¥çšã§ã¢ã¢ãã·ã·ãªã³ã
補é ããåªããæ¹æ³ã§ããããïŒâã¢ããããã·
ã©ã³é
žãšåå¿ãããâïœâããããã·ããšãã«
ã°ãªã·ã³æŽ»æ§èªå°äœã¯ãäžè¬ã«ïŒâïŒïœâãã€ã
ããã·ããšãã«ïŒããã³ãã€ã³ã®å æ°Žå解工çšã
äœãåŸãããã®å
åŠåå²å·¥çšåã³æŽ»æ§èªå°äœãš
ããããã®ãšã¹ãã«ååã¯ã¢ããåå·¥çšçç
©éãª
å·¥çšãçµãŠè£œé ãããŠããããå¿
ãããæºè¶³ãã¹
ããã®ãšã¯ãããªãã
æ¬çºæè
çã«ããç°¡åãªå·¥çšã§å¹ççã«ã¢ã¢ã
ã·ã·ãªã³ãé
µçŽ çã«è£œé ããæ¹æ³ãéçºãã¹ãé
æç ç©¶ãéããçµæããã©ããã¯ããªãŠã å±ã«å±
ãã埮çç©ã®å¹é€ç©åã¯ãã®åŠçç©ã®å
±åäžã§ã
ïŒâã¢ããããã·ã©ã³é
žãšïŒâïŒïœâãã€ããã
ã·ããšãã«ïŒããã³ãã€ã³ãåå¿ããããšãã¢ã¢
ãã·ã·ãªã³ãäžå·¥çšã§çŽæ¥ã«çç£ã§ããããšãçº
èŠãæ¬çºæã宿ããã«è³ã€ããå³ã¡ãæ¬çºæã¯
ãã©ããã¯ããªãŠã å±ã«å±ããïŒâã¢ããããã·
ã©ã³é
žãšïŒâïŒïœâãã€ãããã·ããšãã«ïŒãã
ã³ãã€ã³ãšããã¢ã¢ãã·ã·ãªã³ãåæããèœåã
æãã埮çç©ã®å¹é€ç©åã¯ãã®åŠçç©ã®ååšäž
ã§ãïŒâã¢ããããã·ã©ã³é
žãšïŒâïŒïœâããã
ãã·ããšãã«ïŒããã³ãã€ã³ãåå¿ãããŠã¢ã¢ã
ã·ã·ãªã³ãçæããããããšãç¹åŸŽãšããã¢ã¢ã
ã·ã·ãªã³ã®é
µçŽ çè£œé æ³ã§ããã
æ¬çºæã®æ¹æ³ã§äœ¿çšãã埮çç©ãšããŠããã©ã
ãã¯ããªãŠã å±ã«å±ããïŒâïŒïœâãã€ãããã·
ããšãã«ïŒããã³ãã€ã³ãšïŒâã¢ããããã·ã©ã³
é
žãšããã¢ã¢ãã·ã·ãªã³ãåæããé
µçŽ ãçç£ã
ãèœåãæãã埮çç©äŸãã°ãã©ããã¯ããªãŠ
ã ã»ããã³ãã€ããã€ã©ã AJ 11322ãFERMâ
 4819ãå©çšã§ãããããã®èæ ªã«éãããå
æé
µçŽ ãçç£ãããã®ã§ããã°èªç¶æ ªãå€ç°æ ªã
åãããã¹ãŠæ¬çºæã«æŒãŠäœ¿çšããããšãã§ã
ãã
äžèšåŸ®çç©AJ11322æ ªã®èåŠçæ§è³ªã以äžã«èš
èŒããã
AJ11322æ ªã®èåŠçæ§è³ª
(a) 圢 æ
(1) 现èã®åœ¢ããã³å€§ããïŒçèç¶ãçæ¡¿è
0.4ãïŒÃïŒã2.5ÎŒ
(2) 现èã®å€åœ¢æ§ã®æç¡ïŒãªã
(3) éåæ§ã®æç¡ã鿝ã®ççç¶æ
ïŒãªã
(4) èåã®æç¡ïŒãªã
(5) ã°ã©ã æè²æ§ïŒé°æ§
(6) æé
žæ§ïŒé°æ§
(b) åå¹å°ã«ãããçè²ç¶æ
(1) èæ±å¯å€©æ¿å¹é€ïŒé©åºŠãªçè²ãå圢ãåžå
ç¶ãéèµ·ç¶ãå
šçžãåéæã湿å
ãå質ãå
æ»ãããè²ãã¹ããè²
(2) èæ±å¯å€©æé¢å¹é€ïŒé©åºŠãªçè²ãèèç¶ã
糞ç¶ãããè²ãã¹ããè²
(3) èæ±æ¶²äœå¹é€ïŒåäžã«æ¿ã
(4) èæ±ãŒã©ãã³ç©¿åºå¹é€ïŒæ¶²åããªãã
(5) ãªããã¹ã»ãã«ã¯ïŒæ¶²åããªãã匱ã¢ã«ã«
ãªæ§
(c) ççåŠçæ§è³ª
(1) ç¡é
žå¡©ã®éå
ïŒïŒ
(2) è±çªåå¿ïŒâ
(3) MRãã¹ãïŒâ
(4) VPãã¹ãïŒâ
(5) ã€ã³ããŒã«ã®çæïŒâ
(6) ç¡«åæ°ŽçŽ ã®çæïŒâ
(7) ãã³ãã³ã®å æ°Žåè§£ïŒâ
(8) ã¯ãšã³é
žã®å©çšïŒKoserå¹å°ã§å©çšããªã
Christensenå¹å°ã§å©çšãã
(9) ç¡æ©çªçŽ æºïŒç¡é
žå¡©ãå©çšããªã
ã¢ã³ã¢ããŠã å¡©ãå©çšããªã
(10) è²çŽ ã®çæïŒçæããªã
(11) ãŠã¬ã¢ãŒãŒïŒâ
(12) ãªãã·ããŒãŒïŒïŒ
(13) ã«ã¿ã©ãŒãŒïŒïŒ
(14) çè²ã®ç¯å²ïŒ
枩床37âã§çè²ããã41âã§çè²ããªã
PHïŒãïŒ
(15) é
žçŽ ã«å¯Ÿããæ
床ïŒå¥œæ°æ§
(16) âãã¹ãïŒHughïŒLeifsonæ³ã«ã
ãïŒïŒïŒ¯
(17) ç³é¡ããé
žããã³ã¬ã¹ã®çæã®æç¡ãã
ããã³å¹å°ã
The present invention relates to a method for the enzymatic production of amoxicillin, and more particularly to a method for the enzymatic production of amoxicillin and 5-aminopenicillanic acid.
The present invention relates to an enzymatic method for producing amoxicillin directly from (p-hydroxyphenyl)hydantoin. Amoxicillin (6-[D-(-)-α-amino-D-hydroxyphenylacetamide] penicillanic acid) is an excellent antibiotic substance with strong antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria. In recent years, they have come to occupy a particularly important position as chemotherapeutic agents for various infectious diseases of humans and animals caused by contamination with these bacteria. Chemical synthesis methods and enzymatic production methods are known for the production of amoxicillin, but the chemical synthesis methods require steps such as introduction and removal of a protecting group, and conversion of an acyl donor into an active derivative. Since the entire reaction process is complex and diverse, enzymatic production methods have been developed as an alternative. However, in the conventionally known enzymatic production method, the substrate 6-aminopenicillanic acid and the active derivative of D-p-hydroxyphenylglycillin are mixed with the cells of microorganisms belonging to the genus Pseudomonas, Achromobacter, Bacillus, etc. This is an excellent method for producing amoxicillin in one step by enzymatic reaction in the presence of the treated product. is generally a step of hydrolyzing 5-(p-hydroxyphenyl)hydantoin,
Since it is produced through complicated steps such as an optical resolution step to obtain D-form and an esterification or amidation step to obtain an active derivative, it cannot be said to be necessarily satisfactory. As a result of extensive research by the present inventors to develop a method for enzymatically producing amoxicillin efficiently in a simple process, in the coexistence of a culture of a microorganism belonging to the genus Flavobacterium or a processed product thereof,
The inventors discovered that amoxicillin can be directly produced in one step by reacting 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin, leading to the completion of the present invention. That is, the present invention relates to a microorganism that belongs to the genus Flavobacterium and has the ability to synthesize amoxicillin from 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin in the presence of a culture or a processed product thereof. , 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin are reacted to produce amoxicillin, which is an enzymatic method for producing amoxicillin. The microorganisms used in the method of the present invention belong to the genus Flavobacterium and have the ability to produce an enzyme that synthesizes amoxicillin from 5-(p-hydroxyphenyl)hydantoin and 6-aminopenicillanic acid, such as Flavo. Bacterium hydantoinophilum AJ 11322, FERMâ
P4819 can be used, but it is not limited to this strain; any strain, whether natural or mutant, that produces a synthetic enzyme can be used in the present invention. The mycological properties of the above microorganism strain AJ11322 are described below. Mycological properties of strain AJ11322 (a) Morphology (1) Cell shape and size: coccoid to short bacillus
0.4-1Ã1-2.5ÎŒ (2) Presence or absence of cell pleomorphism: None (3) Presence or absence of motility, epiphytic status of flagella: None (4) Presence or absence of spores: None (5) Gram staining: Negative (6) Acid-fast: Negative (b) Growth status in each medium (1) Broth agar plate culture: Moderate growth, circular, convex circular to ridged, full edges, translucent, moist light, homogeneous, smooth, Buff color to straw color (2) Juicy agar slant culture: Moderate growth, thin film-like,
Stringy, buff to straw color (3) Meat juice liquid culture: uniformly cloudy (4) Meat juice gelatin puncture culture: does not liquefy. (5) Litmus milk: does not liquefy, weakly alkaline (c) Physiological properties (1) Nitrate reduction: + (2) Denitrification reaction: - (3) MR test: - (4) VP test: - (5 ) Production of indole: - (6) Production of hydrogen sulfide: - (7) Hydrolysis of starch: - (8) Utilization of citric acid: Not used in Koser medium
Used in Christensen medium (9) Inorganic nitrogen source: Do not use nitrates. Do not use ammonium salts. (10) Pigment production: No production. (11) Urease: - (12) Oxidase: + (13) Catalase: + (14) ) Growth range: Grows at a temperature of 37â, but does not grow at 41â PH6-9 (15) Attitude towards oxygen: Aerobic (16) O-F test (by Hugh & Leifson method): O (17) From sugars to acids and Presence or absence of gas generation [Peptone medium]
ã衚ã
(18) ã°ã«ã³ã³é
žã®é
žåïŒHaynesã®æ¹æ³ïŒïŒ
â
(19) ããšãã«ã¢ã©ãã³ã®ãã¢ãããŒãŒåå¿
ïŒEwing etalã®æ¹æ³ïŒïŒâ
(20) ãã«ã«ããã·ã©ãŒãŒåå¿ïŒïŒÏllerã®æ¹
æ³ïŒïŒãªãžã³ â
ãªã«ããã³ â
ã¢ã«ã®ãã³ â
(21) ã¢ã«ã®ãã³ãžãããã©ãŒãŒåå¿
ïŒStanieret alã®æ¹æ³ïŒïŒNT
(22) ã«ãŒã€ã³ã®åè§£æ§ïŒâ
(23) DNAã®åè§£æ§ïŒâ
(24) Polyâβâhydroxybutyrateã®èç©ã®æ
ç¡ïŒãªã
(25) æ é€èŠæ±æ§ïŒãã
(26) ã»ã«ããŒã¹ã®åè§£æ§ïŒâ
(27) èå¡©æ§ïŒé£å¡©ïŒïŒ
ã§çè²ããªã
(d) DNAã®GO嫿éïŒ69.5ïŒ
æ¬èã¯ã°ã©ã é°æ§æ¡¿èãééåæ§ãå¥œæ°æ§ã
ã«ã¿ã©ãŒãŒéœæ§ããªãã·ããŒãŒéœæ§ãç³ãé
žå
çã«åŸã
ã«åè§£ããŠé
žãçæããéèœã®è²èª¿ã
ããè²ãã¹ããè²ã§ããããšãããã©ããã¯ã
ãªãŠã å±ã«å±ããã
çš®ã«ã€ããŠæ€çŽ¢ãããšBergey Manual第ïŒç
èšèŒã®æ¢ç¥èçš®ãšæ¬èãšã§ã¯éåæ§ãèå¡©æ§ã
37âã«æŒããçè²ã®æç¡ããŒã©ãã³åè§£æ§ãã»
ã«ããŒã¹åè§£æ§ãDNAã®GOå«éãªã©ã®éèŠæ§
ç¶ã§äžèŽããªãã
åŸã€ãŠæ¬èãæ°èçš®ãšèªããŠ
Flavobacterium hydantoinophilumãã©ããã¯
ããªãŠã ã»ããã€ã³ãããã€ã©ã ãšåœåããã
æ¬çºæã®æ¹æ³ã§äœ¿çšãã埮çç©ã®äžã«ã¯çæã
ããã¢ã¢ãã·ã·ãªã³ã«äœçšããŠããã倿ããæ
害é
µçŽ ãäŸãã°Î²âã©ã¯ã¿ããŒãŒãã¢ãããŒãŒç
ãçç£ãããã®ããããããã®å Žåã«ã¯æå®³é
µçŽ
ãçæããªãå€ç°æ ªãè²çš®ããããšãæãŸããã
ã¢ã¢ãã·ã·ãªã³åæé
µçŽ ãçç£ãã埮çç©ãçš
ããŠãç®çã®ã¢ã¢ãã·ã·ãªã³ã補é ããã«ã¯éåžž
ãŸããããã®åŸ®çç©ãæ é€å¹å°ã§å¹é€ããåŸãã
ãå¹é€ç©ãŸãã¯ãã®åŠçç©ã®ååšäžã§ïŒâã¢ãã
ããã·ã©ã³é
žãšïŒâïŒïœâãã€ãããã·ããšã
ã«ïŒããã³ãã€ã³ãåå¿ãããã°ããããå¹å°å
ã¯å¹é€äžã«ïŒâã¢ããããã·ã©ã³é
žãšïŒâïŒïœâ
ãã€ãããã·ããšãã«ïŒããã³ãã€ã³ãæ·»å ãã
埮çç©ã®å¹é€ãšåæã«é
µçŽ åå¿ãè¡ããã¢ã¢ãã·
ã·ãªã³ã補é ããããšãã§ããã
埮çç©ã®å¹é€ã«çšããå¹å°ã¯ççŽ æºãçªçŽ æºã
ç¡æ©ã€ãªã³ãæŽã«å¿
èŠã«å¿ããŠãã¿ãã³ãã¢ãã
é
žãé
µæ¯ãšãã¹çææ©åŸ®éæ é€çŽ ãå«ãéåžžã®æ
é€å¹å°ãçšãããããäžèšççŽ æºãšããŠã¯ãã°ã«
ã³ãŒã¹ãã·ãŠãŒã¯ããŒã¹ããã«ããŒã¹ãæŸ±ç²æ°Žè§£
ç©çã®çæ°Žåç©ãé
¢é
žããšã¿ããŒã«çãé©å®äœ¿çš
ããããåãçªçŽ æºãšããŠã¯ã¢ã³ã¢ãã¢ã¬ã¹ãã¢
ã³ã¢ãã¢æ°Žãã¢ã³ã¢ããŠã å¡©ããããã³ãèãšã
ã¹ãé
µæ¯ãšãã¹ã忀ç©èçœè³ªã®å æ°Žåè§£ç©çã
çšãããããç¡æ©ã€ãªã³ãšããŠã¯ãã°ãã·ãŠã ã€
ãªã³ãã«ãªã€ãªã³ããããªãŠã ã€ãªã³ãã«ã«ã·ãŠ
ã ã€ãªã³ãéã€ãªã³ããã³ã¬ã³ã€ãªã³çãå¿
èŠã«
å¿ããŠé©å®çšããããã
ããã«ãã¢ã¢ãã·ã·ãªã³åæé
µçŽ ã®æŽ»æ§ãé«ã
ããããDLâïŒâã¡ãã«ã¡ã«ã«ãããšãã«ãã
ã³ãã€ã³ãDLâïŒâã€ã³ããªã«ã¡ãã«ããã³ã
ã€ã³ãDLâïŒâïŒïœâãã€ãããã·ããšãã«ïŒã
ãã³ãã€ã³ç第ïŒè¡šã«ç€ºãïŒâ眮æããã³ãã€ã³
èªå°äœãé©å®å¹å°ã«æ·»å ããããšãæãŸãããå¹
å°ã«0.1ã0.5ïœïŒdlæ·»å ããããšã«ãããé
µçŽ æŽ»
æ§ã¯ïŒãïŒåã«å¢å€§ããããšãã§ããã
å¹é€æž©åºŠã¯åŸ®çç©ã®çè²ã«é©ããæž©åºŠç¯å²ã§ã
ãã°ããã15ã40âã奜ãŸããã¯25ã37âã§ã
ããå¹é€æéã¯äœ¿çšããèæ ªã®çš®é¡ãå¹é€æ¡ä»¶ç
ã«ãã€ãŠå€åãããåæé
µçŽ ã®é
µçŽ æŽ»æ§ãæå€§ãš
ãªã€ãæç¹ã§å¹é€ãçµäºããã°ãããéåžž16ã48
æéãé©åœã§ããã
ãã®ããã«ããŠåŸãããå¹é€ç©åã¯ãã®åŠçç©
ãã¢ã¢ãã·ã·ãªã³ã®çæåå¿ã«å¿çšãããããã
ãã§ããå¹é€ç©ãšã¯å¹é€æ¶²èªäœã®ã»ããå¹é€æ¶²ã
ãåé¢ããçèäœãåã¯å¹é€æ¶²ããèäœçäžæº¶æ§
ç©è³ªãé€å»ããå¹é€æ¶²ïŒäžæŸæ¶²ïŒãæãããã®
åŠçç©ãšã¯ãäžèšå¹é€ç©ã«é©åœãªåŠçãæœããŠã¢
ã¢ãã·ã·ãªã³åæé
µçŽ ã®é
µçŽ æŽ»æ§ãé«ããããé·
æéå®å®ã«æŽ»æ§ãæç¶ãããçãã¢ã¢ãã·ã·ãªã³
ã®è£œé ã«ããé©ããç¶æ
ã«åŠçãããã®ãããã
äŸãã°æ¬åæé
µçŽ ãèäœå€é
µçŽ ã§ããã°ãäžèš
å¹é€æ¶²ããå¡©æãéæãåžçã»ã€ãªã³äº€æã¯ã
ãããŒã°ã©ãã€ãŒãã²ã«éãªã©å
¬ç¥ã®é
µçŽ ç²Ÿè£œ
ææ®µãé©å®åç¬åã¯äœµçšããããšã«ãã粟補ãã
ããã¯éšå粟補ããé
µçŽ ãåã¯äžèšé
µçŽ ãæ°Žã«äž
溶æ§ã®æ
äœã«åžçãããã¯å
æ¬åºå®åããããåº
å®åé
µçŽ çãæããæ¬åæé
µçŽ ãèæ ªå
é
µçŽ ã§ã
ãå Žåã«ã¯å¹é€æ¶²ããåé¢ããçèäœãæ°Žã§æŽæµ
åŸãã¢ã»ãã³ãã¡ã¿ããŒã«ããšã¿ããŒã«çææ©æº¶
åªã§åŠçããŠåŸãããææ©æº¶åªåŠçèäœãçèäœ
ã«ç£šç ãè¶
鳿³¢åŠçã现è壿º¶è§£é
µçŽ åŠçãåã¯
ç颿޻æ§å€åŠççã®ç©ççãååŠçåŠçãæœãã
èæ ªããããåŠçèæ ªãæ°Žãç·©è¡æ¶²çã§æœåºãã
ç¡çŽ°èæœåºæ¶²ãåã³ãã®ç²Ÿè£œé
µçŽ ãåºå®åé
µçŽ ã
ãããã¯åºå®å埮çç©çãããã
ãããå¹é€ç©ãšãã®åŠçç©ãçšããŠïŒâã¢ãã
ããã·ã©ã³é
žãšïŒâïŒïœâãã€ãããã·ããšã
ã«ïŒããã³ãã€ã³ãšããã¢ã¢ãã·ã·ãªã³ã補é ã
ãéã®é
µçŽ åå¿ã¯ã氎溶液äžã§ãè¡ãããããå
çã®é¢ããã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœããã
ããŒã«ãã¢ã»ãã³ãã¡ãã«ã»ã«ãœã«ãããžãªããµ
ã³ãïœâãã¿ããŒã«çã®èŠªæ°Žæ§ææ©æº¶åªãïŒã20
ïŒ
å«ã氎溶液äžã§è¡ãããšãããæãŸããã
é
µçŽ åå¿ãè¡ãéã®åå¿PHã¯4.0ã9.0ãåå¿æž©
床ã¯20ã50âã§è¡ããããé
µçŽ ãæ°Žã«å¯æº¶æ§ã®å Ž
åäžèšé
µçŽ åå¿ã¯æº¶æ¶²äžã§è¡ãããããé
µçŽ ãæ°Ž
ã«äžæº¶ã®å Žååã¯åºå®åé
µçŽ ã®å Žåã«ã¯æžæ¿æ¶²äž
åã¯ã«ã©ã äžã«æŒãŠåå¿ãè¡ããããå埮çç©ã
å¹é€ããéã®å¹å°ãããã¯å¹é€äžã«ïŒâïŒïœâã
ã€ãããã·ããšãã«ïŒããã³ãã€ã³ãšïŒâã¢ãã
ããã·ã©ã³é
žãæ·»å ããŠå¹é€ããã°ã埮çç©ã®å¹
é€å³ã¡é
µçŽ ã®çç£ãšã¢ã¢ãã·ã·ãªã³ã®åæãåæ
ã«è¡ãããã®ã§äŸ¿å©ã§ããã
é
µçŽ åå¿æéã¯åºè³ªã®æ¿åºŠãé
µçŽ æŽ»æ§ãPHã借
éäžçŽç©ã®çš®é¡ãéãåå¿æž©åºŠçåå¿æ¡ä»¶ã«ãã€
ãŠå·Šå³ãããããèŠã¯ã¢ã¢ãã·ã·ãªã³ã®çæéã
æå€§ã«éããæã«åå¿ãçµäºããã°ããéåžžïŒã
10æéã§ååã§ããã
æ¬çºæã§çšããïŒâã¢ããããã·ã©ã³é
žã¯éé¢
ã®åœ¢ã§ãããåãããªãŠã å¡©ãã«ãªãŠã å¡©çå¡©ã®
圢ã§ã䜿çšãããïŒâïŒïœâãã€ãããã·ããšã
ã«ïŒããã³ãã€ã³ã¯ïŒ€äœãäœãDLäœã®ããã
ã§ããããDLäœãçŽæ¥äœ¿çšã§ããã®ã§å·¥æ¥ç補
é æ³ãšããŠã¯æ¥µããŠäŸ¿å©ã§ããã
ãã®ããã«ããŠåŸãããåå¿æ¶²ããã¢ã¢ãã·ã·
ãªã³ãæ¡åããæ¹æ³ãšããŠã¯ãå
¬ç¥ã®æ¹æ³ã«æºã
ãŠè¡ãã°ãããäŸãã°æªåå¿ã®ïŒâïŒïœâãã€ã
ããã·ããšãã«ïŒããã³ãã€ã³ã¯æ°Žã«æº¶ãã«ãã
ç©è³ªã§ããããšãããåå¿æ¶²ãé å¿åé¢ããããš
ã®æªåå¿ã®ïŒâïŒïœâãã€ãããã·ããšãã«ïŒã
ãã³ãã€ã³ã®å€§éšååã³èæ ªçã®äžæº¶æ§ç©è³ªãé€
å»ãããã
ããã§ãã®æ¶²ãHPâ20çåžçæš¹èã«ã©ã ã«é
ããŠã¢ã¢ãã·ã·ãªã³ãåžçããææ©æº¶åªãæ°Žãªã©
ã®é©åœãªæº¶åªã§æº¶åºããã¢ã¢ãã·ã·ãªã³ãå«ãåº
åãæ¿çž®ããé©åœãªèŠªæ°Žæ§ææ©æº¶åªãå ããŠæ¶æ
ããããšã«ããã¢ã¢ãã·ã·ãªã³ãæ¡åããããšã
ã§ããã
äžè¿°ã®åŠããæ¬çºæã¯ïŒâã¢ããããã·ã©ã³é
ž
ãšïŒâïŒïœâãã€ãããã·ããšãã«ïŒããã³ãã€
ã³ãšããçŽæ¥ã¢ã¢ãã·ã·ãªã³ã補é ããæ°ããã¢
ã¢ãã·ã·ãªã³ã®é
µçŽ çè£œé æ³ãæäŸãããã®ã§ã
ãã以äžå®æœäŸã«ãŠæ¬çºæãå
·äœçã«èª¬æããã
宿œäŸ ïŒ
ã°ã«ã³ãŒã¹2.0ïœïŒdlãïŒNH4ïŒ2SO40.5ïœïŒdlã
KH2PO40.1ïœïŒdlãK2HPO40.3ïœïŒdlã
MgSO4ã»7H2O0.05ïœïŒdlãFeSO4ã»7H2O1mgïŒ
dlãMnSO4ã»4H2O1mgïŒdlãé
µæ¯ãšãã¹1.0ïœïŒ
dlããããã³1.0ïœïŒdlãDLâïŒâã¡ãã«ã«ãã
ãšãã«ããã³ãã€ã³0.2ïœïŒdlãçé
žã«ã«ã·ãŠã
ïŒå¥æ®ºèïŒãå«ãå¹å°ïŒPH7.0ïŒã500ml容ãã©ã¹
ã³ã«50mlå®å
¥ã120âã§15åéæ®ºèããã
ããã«ãã€ãšã³å¯å€©å¹å°ã§30âã«ãŠ24æéå¹é€
ãããã©ããã¯ããªãŠã ã»ããã³ãã€ããã€ã«ã
AL 11322FERMâP4819ãïŒçœéè³æ¥çš®ã30â
ã§20æéå¹é€ããããã®å¹é€æ¶²ããèäœãé å¿å
é¢ã«ããæ¡åããå¹é€æ¶²ãšåéã®ççé£å¡©æ°Žã§ïŒ
åæŽæµãèäœãéããã
ãã®èäœãïŒâã¢ããããã·ã©ã³é
ž0.5ïœïŒdl
åã³DLâïŒâïŒïœâãã€ãããã·ããšãã«ïŒãã
ã³ãã€ã³ïŒïœïŒdlãå«ã0.05MïŒdlãªã³é
žç·©è¡æ¶²
ïŒçµæ«PH7.0ãïŒmlïŒã«ïŒïœïŒdlã«ãªãããã«æ·»å
ããïŒæé30âã«ä¿æåå¿ããããåå¿åŸãèäœ
ãé å¿åé¢ã§é€å»ããåå¿æ¶²äžã«çæããã¢ã¢ã
ã·ã·ãªã³ãã«ããªã³äº€ææš¹èïŒããŠãã³ç€Ÿè£œã®
ãZIPAXâSCXã䜿çšïŒãçšããé«éæ¶²äœã¯ãã
ãã°ã©ãã€ãŒã§å®éãã54.6ÎŒïœïŒmlã®ã¢ã¢ãã·
ã·ãªã³ãåŸãã
å°ãåå¿çæããã¢ã¢ãã·ã·ãªã³ãïœâãã¿ã
ãŒã«ïŒé
¢é
žïŒæ°ŽïŒïŒïŒïŒïŒïŒãïœâãããããŒ
ã«ïŒæ°ŽïŒïŒïŒïŒãçšããèå±€ã¯ãããã°ã©ãã€ãŒ
ã§æ¯èŒãããšããæšæºæšåã®ã¢ã¢ãã·ã·ãªã³ãšå®
å
šã«äžèŽããããŸããããããŠã¹ãã©ããªã¹ãçš
ãããã€ãªã¢ãã»ã€æ³ã«ãã€ãŠçæéã確èªãã
æã»ãŒåäžã®çµæãåŸãããã
宿œäŸ ïŒ
ã°ã«ã³ãŒã¹2.0ïœïŒdlãïŒNH4ïŒ2SO40.5ïœïŒdlã
KH2PO40.1ïœïŒdlãK2HPO40.3ïœïŒdlã
MgSO4ã»7H2O0.05ïœïŒdlãFeSO4ã»7H2O1mgïŒ
dlãMnSO4ã»4H2O1mgïŒdlãé
µæ¯ãšãã¹1.0ïœïŒ
dlããããã³1.0ïœïŒdlãçé
žã«ã«ã·ãŠã ïŒå¥æ®º
èïŒãå«ãå¹å°ïŒPH7.0ïŒã500ml容ãã©ã¹ã³ã«50
mlå
¥ã120âã15åéæ®ºèããã
ããã«ãã€ãšã³å¯å€©å¹å°ã§30âã«ãŠ24æéå¹é€
ãããã©ããã¯ããªãŠã ã»ããã³ãã€ããã€ã«ã
FERMâP4819ãæ¥çš®ãã30âã§16æéå¹é€ã
ããå¹é€æ¶²ã«ç¬¬ïŒè¡šã«ç€ºãïŒâ眮æã·ãã³ãã€ã³
ïŒå¥æ®ºèãããã®ïŒã0.2ïœïŒdlã«ãªãããã«æ·»å
ããæŽã«ïŒæéå¹é€ãç¶ããããã®å¹é€æ¶²ããè
æ ªãé å¿åé¢ã«ããæ¡åããå¹é€æ¶²ãšåéã®çç
é£å¡©æ°Žã§ïŒåæŽæµãèæ ªãéããã
ãã®èæ ªãïŒâã¢ããããã·ã©ã³é
ž0.5ïœïŒdl
ãšDLâïŒâïŒïœâãã€ãããã·ããšãã«ïŒããã³
ãã€ã³ïŒïœïŒdlãå«ã0.05Mãªã³é
žç·©è¡¡æ¶²ïŒçµæ«
PH7.0 ïŒmlïŒã«ïŒïœïŒdlã«ãªãããã«æ·»å ããïŒ
æé30âã«ä¿æåå¿ããããåå¿åŸèäœãé å¿å
é¢ã§é€å»ããåå¿æ¶²äžã«çæããã¢ã¢ãã·ã·ãªã³
ã宿œäŸïŒãšåæ§ã®æ¹æ³ã§å®éããããã®çµéã
第ïŒè¡šã«ç€ºããã[Table] (18) Oxidation of gluconic acid (Haynes method):
- (19) Deaminase reaction of phenylalanine (method of Ewing et al): - (20) Decarboxylase reaction (method of MÏller): Lysine - Ornithine - Arginine - (21) Arginine dihydrolase reaction (method of Stanier et al): NT (22) Degradability of casein: - (23) Degradability of DNA: - (24) Accumulation of poly-β-hydroxybutyrate: None (25) Auxotrophy: Yes (26) Degradability of cellulose: - (27) Salt tolerance: Does not grow in 3% salt (d) DNA GO content: 69.5% This bacterium is a Gram-negative bacillus, non-motile, aerobic,
It belongs to the genus Flavobacterium because it is catalase positive, oxidase positive, gradually decomposes sugar oxidatively to produce acid, and the color tone of the colony is buff to straw color. When searching for species, the known bacterial species described in the Bergey Manual 8th edition and this bacteria are motile, salt tolerant,
They do not match in important properties such as growth at 37â, gelatin decomposition property, cellulose decomposition property, GO content of DNA, etc. Therefore, this bacterium is recognized as a new bacterial species.
It was named Flavobacterium hydantoinophilum. Some of the microorganisms used in the method of the present invention produce harmful enzymes, such as β-lactamase and amidase, which act on and convert the produced amoxicillin; It is desirable to breed mutant strains that do not. To produce the desired amoxicillin using microorganisms that produce amoxicillin synthase, these microorganisms are usually first cultured in a nutrient medium, and 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin may be reacted with 6-aminopenicillanic acid and 5-(p-
Add hydroxyphenyl) hydantoin,
Amoxicillin can also be produced by culturing microorganisms and carrying out an enzyme reaction simultaneously. The medium used for culturing microorganisms contains carbon sources, nitrogen sources,
A conventional nutrient medium containing inorganic ions and, if necessary, organic micronutrients such as vitamins, amino acids, and yeast extract is used. As the carbon source, carbohydrates such as glucose, sucrose, maltose, starch hydrolyzate, acetic acid, ethanol, etc. are used as appropriate. Further, as the nitrogen source, ammonia gas, aqueous ammonia, ammonium salt, peptone, meat extract, yeast extract, hydrolyzate of animal and plant proteins, etc. are used. As the inorganic ions, magnesium ions, potassium ions, sodium ions, calcium ions, iron ions, manganese ions, etc. are used as appropriate. Furthermore, in order to increase the activity of amoxicillin synthase, 5-substitutions shown in Table 1 such as DL-5-methylmercaptoethylhydantoin, DL-5-indolylmethylhydantoin, DL-5-(p-hydroxyphenyl)hydantoin, etc. It is desirable to add a hydantoin derivative to the medium as appropriate, and by adding 0.1 to 0.5 g/dl to the medium, the enzyme activity can be increased 4 to 5 times. The culture temperature may be within a temperature range suitable for the growth of microorganisms, and is 15 to 40°C, preferably 25 to 37°C. The culture time varies depending on the type of strain used, culture conditions, etc., but it is sufficient to terminate the culture when the enzymatic activity of the synthetic enzyme reaches its maximum, which is usually 16 to 48 hours.
The time is appropriate. The culture obtained in this way or its treated product is applied to the production reaction of amoxicillin, but the culture here refers to the culture solution itself, as well as viable bacterial bodies isolated from the culture solution, or bacteria from the culture solution. This refers to the culture fluid (supernatant) from which insoluble substances such as body fluids have been removed, and the treated product refers to the culture fluid that has been subjected to appropriate treatments to increase the enzymatic activity of amoxicillin synthase or maintain its activity stably for a long period of time. It refers to amoxicillin that has been processed to a state more suitable for manufacturing amoxicillin. For example, if the present synthetic enzyme is an extracellular enzyme, it can be purified from the above-mentioned culture solution by using known enzyme purification methods such as salting out, dialysis, adsorption/ion exchange chromatography, and gel filtration as appropriate, alone or in combination; It refers to a partially purified enzyme, or an immobilized enzyme obtained by adsorbing or comprehensively immobilizing the above enzyme on a water-insoluble carrier, and if the synthetic enzyme is an intra-strain enzyme, it refers to a live bacterial cell isolated from a culture solution. Organic solvent-treated bacterial cells obtained by washing with water and treatment with an organic solvent such as acetone, methanol, or ethanol, or physical treatment such as grinding, ultrasonication, cell wall lytic enzyme treatment, or surfactant treatment to viable bacterial cells. , chemically treated bacterial strains, cell-free extracts obtained by extracting these treated bacterial strains with water, buffer solutions, etc., and their purified enzymes, immobilized enzymes,
Or immobilized microorganisms, etc. The enzymatic reaction for producing amoxicillin from 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin using these cultures and their treated products is carried out in an aqueous solution, but from the viewpoint of yield. Hydrophilic organic solvents such as methanol, ethanol, isopropanol, acetone, methylcellosolve, dioxane, t-butanol, etc.
It is more desirable to carry out in an aqueous solution containing %. The enzyme reaction is carried out at a reaction pH of 4.0 to 9.0 and a reaction temperature of 20 to 50°C. When the enzyme is soluble in water, the enzymatic reaction is carried out in a solution, but when the enzyme is insoluble in water or is an immobilized enzyme, the reaction is carried out in suspension or in a column. In addition, if 5-(p-hydroxyphenyl)hydantoin and 6-aminopenicillanic acid are added to the medium or culture for culturing microorganisms, microbial culture, that is, enzyme production and amoxicillin synthesis, can occur at the same time. It is convenient because it can be done. Enzyme reaction time depends on reaction conditions such as substrate concentration, enzyme activity, pH, type and amount of contaminants, and reaction temperature, but in short, the reaction should be terminated when the maximum amount of amoxicillin produced is reached. Usually 1~
10 hours is enough. 6-Aminopenicillanic acid used in the present invention may be used in free form or in the form of sodium salt, potassium salt, etc., and 5-(p-hydroxyphenyl)hydantoin is in the D, L, and DL forms. Either method may be used, and since the DL form can be used directly, it is extremely convenient as an industrial production method. Amoxicillin can be collected from the reaction solution obtained in this way by following a known method.For example, unreacted 5-(p-hydroxyphenyl)hydantoin is a substance that is difficult to dissolve in water. Most of the unreacted 5-(p-hydroxyphenyl)hydantoin and insoluble substances such as bacterial strains are removed by centrifuging the reaction solution. Therefore, this solution is passed through an adsorption resin column such as HP-20 to adsorb amoxicillin and eluted with an appropriate solvent such as an organic solvent or water.The fraction containing amoxicillin is concentrated and crystallized by adding an appropriate hydrophilic organic solvent. Amoxicillin can be collected by doing this. As described above, the present invention provides a new enzymatic method for producing amoxicillin directly from 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin. The present invention will be specifically explained below with reference to Examples. Example 1 Glucose 2.0g/dl, (NH 4 ) 2 SO 4 0.5g/dl,
KH 2 PO 4 0.1g/dl, K 2 HPO 4 0.3g/dl,
MgSO 4ã»7H 2 O0.05g/dl, FeSO 4ã»7H 2 O1mg/
dl, MnSO 4ã»4H 2 O1mg/dl, yeast extract 1.0g/
1.0 g/dl of peptone, 0.2 g/dl of DL-5-methylcaptoethylhydantoin, and 50 ml of a medium (PH7.0) containing calcium carbonate (separately sterilized) was poured into a 500 ml flask and sterilized at 120°C for 15 minutes. . Flavobacterium hydantoinophilum was cultured on bouillon agar medium at 30°C for 24 hours.
One platinum loop of AL 11322FERM-P4819 was inoculated at 30°C.
The cells were cultured for 20 hours. Bacterial cells were collected from this culture solution by centrifugation, and diluted with the same amount of physiological saline as the culture solution.
The cells were washed twice and collected. 6-aminopenicillanic acid 0.5g/dl
and DL-5-(p-hydroxyphenyl)hydantoin was added to 0.05 M/dl phosphate buffer (final pH 7.0, 5 ml) containing 1 g/dl to give a concentration of 5 g/dl, and the mixture was heated at 30°C for 3 hours. Retention reaction was performed. After the reaction, the bacterial cells were removed by centrifugation, and the amoxicillin produced in the reaction solution was quantified by high performance liquid chromatography using a cation exchange resin (DuPont's "ZIPAX-SCX"), and it was found to be 54.6 Όg/ml. of amoxicillin was obtained. In addition, when the amoxicillin produced by the reaction was compared by thin layer chromatography using n-butanol:acetic acid:water = 4:1:2 and n-propanol:water = 7:3, it was completely compared with the standard amoxicillin. Agreed. Furthermore, when the production amount was confirmed by a bioassay method using Proteus mirabilis, almost the same results were obtained. Example 2 Glucose 2.0g/dl, (NH 4 ) 2 SO 4 0.5g/dl,
KH 2 PO 4 0.1g/dl, K 2 HPO 4 0.3g/dl,
MgSO 4ã»7H 2 O0.05g/dl, FeSO 4ã»7H 2 O1mg/
dl, MnSO 4ã»4H 2 O1mg/dl, yeast extract 1.0g/
50ml of medium (PH7.0) containing peptone 1.0g/dl and calcium carbonate (separately sterilized) in a 500ml flask.
ml and sterilized at 120°C for 15 minutes. Flavobacterium hydantoinophilum was cultured on bouillon agar medium at 30°C for 24 hours.
FERM-P4819 was inoculated and cultured at 30°C for 16 hours. 5-substituted cydantoin (separately sterilized) shown in Table 1 was added to the culture solution at a concentration of 0.2 g/dl, and the culture was continued for an additional 6 hours. Bacterial strains were collected from this culture solution by centrifugation, washed once with physiological saline in the same amount as the culture solution, and collected. 6-aminopenicillanic acid 0.5g/dl
and 0.05M phosphate buffer (terminated) containing DL-5-(p-hydroxyphenyl)hydantoin 1g/dl
PH7.0 5ml) to a concentration of 5g/dl,
The reaction was maintained at 30°C for a period of time. After the reaction, the bacterial cells were removed by centrifugation, and amoxicillin produced in the reaction solution was quantified in the same manner as in Example 1. The amount of coagulation is shown in Table 1.
ã衚ããtableã
ã衚ã
宿œäŸ ïŒ
宿œäŸïŒã«ç€ºããå¹å°ã«ãã€ãšã³å¯å€©äžã§30â
ã«ãŠ24æéå¹é€ãããã©ããã¯ããªãŠã ã»ããã³
ãã€ããã€ã©ã FERMâP4819ãæ¥çš®ããŠ30âã§
16æéå¹é€ããåŸãå¹é€æ¶²ã«DLâïŒâïœâïŒãã€
ãããã·ããšãã«ïŒããã³ãã€ã³ïŒå¥æ®ºèïŒã
0.4ïœïŒdlã«ãªãããã«æ·»å ããïŒæéå¹é€ãã
ãããã®å¹é€æ¶²ã«ç¡èç©ã«ïŒâã¢ããããã·ã©ã³
é
žãšDLâïŒâïŒïœâãã€ãããã·ããšãã«ïŒãã
ã³ãã€ã³ããããã0.5ïœïŒdlã1.0ïœïŒdlã«ãªã
ããã«æ·»å ããæŽã«ïŒæéå¹é€ãç¶ããã
ãã®å¹é€æ¶²ã®èæ ªãé å¿åé¢ã«ãã€ãŠé€å»ãã
å¹é€æ¶²äžæž
ã«çæããã¢ã¢ãã·ã·ãªã³ã宿œäŸïŒ
ãšåæ§ã®æ¹æ³ã§å®éããçµæ45ÎŒïœïŒmlã§ãã€
ãã
宿œäŸ ïŒ
宿œäŸïŒãšåæ§ã«èª¿è£œãããã©ããã¯ããªãŠ
ã ã»ããã³ãã€ããã€ã©ã FERMâP4819ã®èäœ
ãïŒïœïŒdlã®æ¿åºŠã«ãªãããã«0.5Mãªã³é
žç·©è¡¡
æ¶²ïŒçµæ«10mlïŒã«æ·»å ãã20KCã®è¶
鳿³¢ã«ãŠïŒ
åéåŠçããããã®åŠçç©ãé å¿ãäžæž
æ¶²ãååŸ
ããããã®äžæž
æ¶²ïŒmlã«ïŒâã¢ããããã·ã©ã³é
ž
ãšDLâïŒïŒâïœâãã€ãããã·ããšãã«ïŒããã³
ãã€ã³ããããã0.5ïœïŒdlã1.0ïœïŒdlã«ãªãã
ãã«æ·»å ïŒçµæ«PH7.0ïŒãã30âã§ïŒæéåå¿ã
ããããã®åå¿æ¶²äžæž
ãæž¬å®ãããšãã73.5ÎŒ
ïœïŒmlã®ã¢ã¢ãã·ã·ãªã³ãçæããŠããã
宿œäŸ ïŒ
宿œäŸïŒãšåæ§ã«èª¿è£œãããã©ããã¯ããªãŠ
ã ã»ããã³ãã€ããã€ã©ã FERMâP4819ã®èäœ
ïŒïœãè±ã€ãªã³æ°ŽïŒmlã«å ããŠæžæ¿ããæ°·å·ãã
ã®ã¡ãã¢ã¯ãªã«ã¢ãã750mgãšã¡ãã¬ã³ãã¹ã¢ã¯
ãªã«ã¢ãã45mgãå ããŠæº¶è§£ãããéç¡«é
žã¢ã³ã¢
ããŠã 3.5mgããã³ïŒ®ã»Nâ²âãžã¡ãã«ã¢ãããã
ããªãããªã«ïŒÎŒïŒãå ããŠæ°·å·äžã«é眮ã
ããïŒæéåŸãçæããèäœå«æã²ã«ã50ã¡ãã·
ãŠã®éç¶²ã§è£ããããççé£å¡©æ°Žã§æŽæµãã²ã«åº
å®åç©ã調補ããã
ãã®åºå®åç©ïŒïœãDLâïŒâïŒïœâãã€ããã
ã·ããšãã«ïŒããã³ãã€ã³ïŒïœïŒdlãïŒâã¢ãã
ããã·ã©ã³é
ž0.5ïœïŒdlãå«ã0.05ãªã³é
žç·©è¡¡æ¶²
ïŒPH7.0ïŒïŒmlã«æ·»å ãã30âãïŒæéåå¿ãã
ãããã®åå¿æ¶²äžæž
ãæž¬å®ãããšãã17.8ÎŒïœïŒ
mlã®ã¢ã¢ãã·ã·ãªã³ãçæããŠããã
宿œäŸ ïŒ
宿œäŸïŒã®æ¹æ³ã§èª¿è£œãããã©ããã¯ããªãŠ
ã ã»ããã³ãã€ããã€ã©ã FERMâP4819ã®èäœ
ãïŒâã¢ããããã·ã©ã³é
ž0.5ïœïŒdlãDLâïŒâ
ïŒïœâãã€ãããã·ããšãã«ïŒããã³ãã€ã³1.0
ïœïŒdlãåã³ãšã¿ããŒã«ïŒã20ïŒ
ïŒïŒ¶ïŒïŒ¶ïŒãå«
ã0.05Mãªã³é
žç·©è¡¡æ¶²ïŒçµæ«PH7.0ã5.0mlïŒã«5.0
ïœïŒdlã«ãªãããã«æ·»å ãã30âã§ïŒæéé
µçŽ å
å¿ãè¡ã€ãã第ïŒè¡šã«ç€ºãããã«ãšã¿ããŒã«ãæ·»
å ããããšã«ãã€ãŠã¢ã¢ãã·ã·ãªã³ã®çæéã¯çŽ
ïŒåã«å¢å€§ããã[Table] Example 3 The medium shown in Example 2 was grown on bouillon agar at 30°C.
Flavobacterium hydantoinophyllum FERM-P4819 cultured for 24 hours was inoculated at 30â.
After culturing for 16 hours, add DL-5-p-(hydroxyphenyl)hydantoin (separately sterilized) to the culture solution.
It was added at a concentration of 0.4 g/dl and cultured for 4 hours. To this culture solution, 6-aminopenicillanic acid and DL-5-(p-hydroxyphenyl)hydantoin were added to a sterile solution at a concentration of 0.5 g/dl and 1.0 g/dl, respectively, and the culture was continued for an additional 3 hours. Ta. The bacterial strain in this culture solution is removed by centrifugation,
Example 1 Amoxicillin produced in the culture supernatant
The amount was determined in the same manner as above, and the result was 45 ÎŒg/ml. Example 4 Flavobacterium hydantoinophyllum FERM-P4819 cells prepared in the same manner as in Example 1 were added to a 0.5M phosphate buffer solution (final 10ml) to a concentration of 5g/dl. 5 with 20KC ultrasound
Processed for minutes. The treated product was centrifuged to obtain a supernatant. 6-aminopenicillanic acid and DL-(5-p-hydroxyphenyl)hydantoin were added to 5 ml of this supernatant at a concentration of 0.5 g/dl and 1.0 g/dl, respectively (final pH 7.0). The reaction was carried out at â for 3 hours. When the supernatant of this reaction solution was measured, it was 73.5ÎŒ.
g/ml of amoxicillin was produced. Example 5 1 g of Flavobacterium hydantoinophyllum FERM-P4819 cells prepared in the same manner as in Example 1 was suspended in 4 ml of deionized water, cooled on ice, and then 750 mg of acrylamide and 45 mg of methylenebisacrylamide were added. 3.5 mg of ammonium persulfate and 8 ÎŒl of N·N'-dimethylaminopropionitrile were added, and the mixture was allowed to stand still under ice-cooling. After 1 hour, the resulting gel containing bacterial cells was strained through a 50-mesh wire mesh and washed with physiological saline to prepare an immobilized gel. 2 g of this immobilized product was added to 5 ml of 0.05 phosphate buffer solution (PH7.0) containing 1 g/dl of DL-5-(p-hydroxyphenyl)hydantoin and 0.5 g/dl of 6-aminopenicillanic acid. â for 3 hours. When the supernatant of this reaction solution was measured, it was 17.8ÎŒg/
ml of amoxicillin was produced. Example 6 The cells of Flavobacterium hydantoinophyllum FERM-P4819 prepared by the method of Example 1 were treated with 0.5 g/dl of 6-aminopenicillanic acid and DL-5-
(p-hydroxyphenyl)hydantoin 1.0
g/dl, and 5.0 in 0.05 M phosphate buffer (final pH 7.0, 5.0 ml) containing ethanol 5-20% (V/V).
g/dl, and the enzymatic reaction was carried out at 30°C for 3 hours. As shown in Table 2, the amount of amoxicillin produced was approximately doubled by adding ethanol.
Claims (1)
ãã·ã©ã³é žãšïŒâïŒïœâãã€ãããã·ããšãã«ïŒ
ããã³ãã€ã³ãšããã¢ã¢ãã·ã·ãªã³ãåæããèœ
åãæãã埮çç©ã®å¹é€ç©ãããã¯ãã®åŠçç©ã®
ååšäžã«ïŒâã¢ããããã·ã©ã³é žãšïŒâïŒïœâã
ã€ããã·ãããšãã«ïŒããã³ãã€ã³ãšãåå¿ãã
ãããšãç¹åŸŽãšããã¢ã¢ãã·ã·ãªã³ã®è£œé æ¹æ³ã1 Belongs to the genus Flavobacterium and contains 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)
Amoxicillin, characterized in that 6-aminopenicillanic acid and 5-(p-hydroxyquiphenyl)hydantoin are reacted in the presence of a culture of a microorganism having the ability to synthesize amoxicillin from hydantoin or a treated product thereof. manufacturing method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4257279A JPS55135597A (en) | 1979-04-10 | 1979-04-10 | Preparation of amoxicillin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4257279A JPS55135597A (en) | 1979-04-10 | 1979-04-10 | Preparation of amoxicillin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55135597A JPS55135597A (en) | 1980-10-22 |
| JPS6231919B2 true JPS6231919B2 (en) | 1987-07-10 |
Family
ID=12639773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4257279A Granted JPS55135597A (en) | 1979-04-10 | 1979-04-10 | Preparation of amoxicillin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55135597A (en) |
-
1979
- 1979-04-10 JP JP4257279A patent/JPS55135597A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55135597A (en) | 1980-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4072567A (en) | Compound water-insoluble glucan and process for the production thereof | |
| NZ225225A (en) | Acid urease and its microbial production | |
| US4391910A (en) | Processes for producing thermophilic aspartase | |
| JP3360291B2 (en) | Method for Increasing Yield of γ-Cyclodextrin | |
| JP3235904B2 (en) | Thermostable mannose isomerase, method for producing the same, and method for producing mannose using the same | |
| US5206162A (en) | Process for making D-aminoacylase | |
| US5130240A (en) | Process for producing d-alpha-alanine and/or l-alpha-alanineamide by arthrobacter sp | |
| JPS6231919B2 (en) | ||
| JPH0779696B2 (en) | New preparation and its manufacturing method | |
| JP3122990B2 (en) | Process for producing O-methyl-L-tyrosine and L-3- (1-naphthyl) alanine | |
| JPH01320991A (en) | Production of d-homophenylalanines | |
| US5252470A (en) | D-amidase and process for producing D-α-alanine and/or L-α-alanineamide | |
| US3144395A (en) | Process for preparing 6-aminopenicillanic acid by bacillus megaterium | |
| JPH05211868A (en) | Method for producing alkaline protease | |
| JPS6058068A (en) | Novel amine dehydrogenase and oxidation of amine using it | |
| JP3873512B2 (en) | Method for producing D-3- (2-naphthyl) alanine | |
| JP3027449B2 (en) | Novel cyclomaltodextrinase, method for producing the same, and microorganism producing the enzyme | |
| JP3272416B2 (en) | Novel cyclodextrin glucanotransferase, method for producing the same, and method for producing cyclodextrin using the enzyme | |
| JPH0614772A (en) | New ester hydrolase a and its production | |
| JPH0574353B2 (en) | ||
| JPH01228465A (en) | Novel beta-agarase and production thereof | |
| JP2899071B2 (en) | Method for producing L-α-alanine | |
| JPH0158957B2 (en) | ||
| JPH07184647A (en) | α-L-fucosidase, its production method and Alcaligenes denitrificans sub sp. Denitrificans KSF-0901 strain | |
| JPH0431672B2 (en) |